| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 28-Dec-08 | | Total Revenue | 115,234 | 119,008 | 135,788 | 165,076 | | Cost of Revenue | 87,183 | 89,578 | 100,975 | 120,285 | | | Gross Profit | 28,051 | 29,430 | 34,813 | 44,791 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 24,336 | 24,938 | 27,137 | 28,491 | | Non Recurring | 2,694 | 5,838 | 107,776 | 990 | | Others | 478 | 440 | 521 | 421 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 543 | (1,786) | (100,621) | 14,889 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 457 | 768 | 4,118 | (4,333) | | Earnings Before Interest And Taxes | 1,000 | (1,018) | (96,503) | 10,556 | | Interest Expense | 3,407 | 3,337 | 3,219 | 3,604 | | Income Before Tax | (2,407) | (4,355) | (99,722) | 6,952 | | Income Tax Expense | 324 | (1,824) | 3,151 | 2,454 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,731) | (2,531) | (102,873) | 4,498 | | | Non-recurring Events | | Discontinued Operations |
-
| 133 | 369 | (685) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,731) | (2,398) | (102,504) | 3,813 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,731) | ($2,398) | ($102,504) | $3,813 |
|
0.51% Nasdaq 
0.14 (0.98%) 
Income Statement
